Enfusion (ENFN) Earnings Date, Estimates & Call Transcripts → Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years (From Banyan Hill Publishing) (Ad) Free enfn Stock Alerts $9.57 +0.05 (+0.53%) (As of 05/3/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryUpcoming Earnings DateMay. 9Before Market OpensConfirmedActual EPS (Mar. 12) $0.01 Missed By -$0.02 Consensus EPS (Mar. 12) $0.03 Get Enfusion Earnings AlertsEnter your email address below to receive the latest news and earnings results for ENFN and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueENFN Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ENFN Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Allegiance GoldCould Your Accounts Be Frozen?The US Dollar Is "Finished" A deteriorating economy, global instability, and a weakened banking system have pushed the U.S. financial system to the brink, imperiling the value of your savings and investments.Get your Free Wealth Protection Kit Enfusion Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20251$0.04$0.04$0.04 Q2 20251$0.06$0.06$0.06 Q3 20251$0.07$0.07$0.07 Q4 20251$0.07$0.07$0.07 FY 20254$0.24$0.24 $0.24ENFN Earnings Date and InformationEnfusion last issued its earnings data on March 12th, 2024. The reported $0.01 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.03 by $0.02. The company earned $46.49 million during the quarter, compared to analysts' expectations of $45.56 million. Enfusion has generated $0.08 earnings per share over the last year ($0.08 diluted earnings per share) and currently has a price-to-earnings ratio of 119.6. Earnings for Enfusion are expected to grow by 142.86% in the coming year, from $0.07 to $0.17 per share. Enfusion has confirmed that its next quarterly earnings report will be published on Thursday, May 9th, 2024. Enfusion will be holding an earnings conference call on Thursday, May 9th at 8:30 AM Eastern. Interested parties can register for or listen to the call.. Read More Enfusion Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/9/2024Confirmed)------- 3/12/2024Q4 2023$0.03$0.01($0.02)$0.01$45.56 million$46.49 million11/7/2023Q3 2023$0.03$0.02($0.01)$0.02$43.95 million$44.36 million8/8/2023Q2 2023$0.02$0.02-$0.03$44.58 million$42.72 million5/9/2023Q1 2023$0.01$0.04+$0.03$0.04$41.99 million$40.97 million3/7/2023Q4 2022-$0.01+$0.01$0.01$39.88 million$40.52 million11/10/2022Q3 2022($0.03)$0.02+$0.05$0.02$38.52 million$39.15 million Get the Latest News and Ratings for ENFN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Enfusion and its competitors with MarketBeat's FREE daily newsletter. 8/9/2022Q2 2022($0.04)($0.03)+$0.01($0.03)$35.67 million$36.54 million5/12/2022Q1 2022$0.04$0.03($0.01)$0.16$33.01 million$34.14 million3/24/2022Q4 2021$0.04$0.55+$0.51$3.36$30.52 million$31.85 million Enfusion Earnings - Frequently Asked Questions When is Enfusion's earnings date? Enfusion has confirmed that its next quarterly earnings data will be published on Thursday, May 9th, 2024. Learn more on ENFN's earnings history. Did Enfusion beat their earnings estimates last quarter? In the previous quarter, Enfusion (NYSE:ENFN) missed the analysts' consensus estimate of $0.03 by $0.02 with a reported earnings per share (EPS) of $0.01. Learn more on analysts' earnings estimate vs. ENFN's actual earnings. How much revenue does Enfusion generate each year? Enfusion (NYSE:ENFN) has a recorded annual revenue of $174.54 million. How much profit does Enfusion generate each year? Enfusion (NYSE:ENFN) has a recorded net income of $6.03 million. ENFN has generated $0.08 earnings per share over the last four quarters. What is Enfusion's price-to-earnings ratio? Enfusion (NYSE:ENFN) has a trailing price-to-earnings ratio of 119.64 and a forward price-to-earnings ratio of 136.71. The price/earnings-to-growth ratio is 2.77. What is Enfusion's EPS forecast for next year? Enfusion's earnings are expected to grow from $0.07 per share to $0.17 per share in the next year, which is a 142.86% increase. More Earnings Resources from MarketBeat Related Companies: BASE Earnings PDFS Earnings OPRA Earnings SOUN Earnings MOMO Earnings VTEX Earnings DCBO Earnings ZUO Earnings EVBG Earnings TUYA Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Apple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings? This page (NYSE:ENFN) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchStock-Picking AI Predicts #1 Stock of 2024AltimetryHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlaceThe asset beating inflation by 4xColonial MetalsDid You Get Your Free Bitcoin Yet?Crypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enfusion, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.